Perion Acquires an Advanced AI Company to Accelerate Market Share Expansion and Growth
Article content
Article content
NEW YORK & TEL AVIV, Israel — Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, today announced the acquisition of Greenbids, a cutting-edge AI platform that creates custom algorithms for campaign-level optimization across walled garden platforms such as YouTube, Facebook and Instagram, as well as leading DSPs such as Google DV360 and The Trade Desk. The acquisition strengthens Perion's ability to deliver custom, performance-based advertising at scale, unlocking new revenue opportunities and increasing its ability to gain market share. It is expected to drive higher client retention and positively contribute to Perion's revenue and adjusted EBITDA already this year.
Article content
Greenbids' technology creates custom bidding algorithms, specifically tailored for each brand, aligning every campaign with the KPIs that matter most to their business. It ensures that media investments are more efficient, performance-driven, and accountable. This not only improves outcomes but also gives brands greater control and transparency over how their budgets are spent. Greenbids brings a robust and growing client base of over 80 brands already using its platform, including Spotify, Ford, and Accor.
Spotify leveraged Greenbids' technology for their Wrapped Annual Marketing Initiative across 16 EMEA markets to enhance campaign performance at scale while reducing environmental impact, demonstrating how smart custom algorithms can drive both results and responsibility. Perion will bring this technology globally to leverage its U.S. presence in over 30 countries and deep relationships with agencies and advertisers.
Article content
Lara Faguais, Head of Global media partnerships & strategy at Accor shared: 'At Accor, we're always looking to partner with companies that embody innovation, creativity and performance. With Greenbids, we found a unique opportunity to reduce our carbon emissions while improving media campaign performance. The results speak for themselves—so much so that we've expanded the collaboration across multiple countries, multiple brands and channels.'
Article content
This acquisition expands Perion's addressable market significantly by adding walled garden channels such as YouTube, Facebook, and Instagram, together with AI-driven lower-funnel capabilities, complementing its existing strength in top and mid-funnel environments, including CTV, DOOH, and the open web. Greenbids' technology will be embedded into the Perion One platform, positioning Perion to capture a greater share of performance budgets and drive higher retention through brand-specific optimization at scale.
Article content
Tal Jacobson, Perion's CEO said: 'We see the acquisition of Greenbids as a quantum leap for the Perion One platform capabilities. We are taking another important step forward in advancing Perion One as the platform of choice for brands and agencies where media investment perfectly aligns with brand outcomes. Greenbids' technology adds a powerful layer of algorithmic intelligence tailored to each brand's unique goals. Combined with Perion's multi-channel reach, we now have a scalable advantage that can deliver optimized performance, which is specifically meaningful to advertisers and brands in uncertain financial environments, as we focus on reducing waste and increasing ROI on media spend.'
Article content
'We are excited to welcome the Greenbids team of industry experts to Perion and look forward to working together to unlock greater value for our clients and shareholders,' Jacobson added. 'It's important to note that the Greenbids product will be implemented immediately into the Perion Suite of solutions under the new name of Perion Algo, and the team will become part of the Perion team at day one, which will reduce any PMI challenges as these solutions continue to scale, and enabling our Sales team to introduce these solutions to a broader market quickly.'
Article content
Guillaume Grimbert, CEO and co-founder of Greenbids, said: 'In the past year, we started to hear more and more about Perion from Brands we interacted with which made us curious to understand their new solutions, which is now the Perion One Platform, and that initiated our initial partnership that led to this transaction. Joining Perion allows us to bring our technology into a company that shares our vision for smarter and more sustainable advertising. Together, we have a powerful opportunity to scale advertising intelligence globally and help more brands achieve meaningful business outcomes with greater transparency and impact.'
Article content
Transaction terms
Article content
The transaction terms include $27.5 million in cash paid upon closing, a two-year cash earnout of $22.5 million, and a 3-year employee retention of $15 million in cash and equity.
Article content
This deal structure reflects Perion's disciplined M&A approach — securing immediate access to transformative AI technology and a blue-chip client base while tying future consideration to performance and integration milestones. The earnout incentivizes continued growth and value delivery, ensuring strong alignment with Perion's strategy. Moreover, the retention component aimed to guarantee continuity of Greenbids' highly skilled team, who will support a successful integration and accelerate the combined offering.
Article content
In addition to the strategic rationale, the transaction is expected to be accretive to Perion's adjusted EBITDA and margins from day one. While initial integration begins immediately, the contribution to both adjusted EBITDA and revenue is expected to significantly accelerate from 2026 onward, driven by incremental synergies across technology, go-to-market, and scalability. By embedding Greenbids' advanced AI algorithm into the Perion One platform and leveraging existing infrastructure, we believe that Perion can enhance efficiency, expand its addressable market, and increase customer retention. By minimizing upfront risk and maximizing long-term upside, this transaction structure positions Perion to extract strategic and financial value from day one.
Article content
Greenbids was advised by LUMA Partners.
Article content
About Perion Network Ltd.
Article content
Perion is helping agencies, brands and retailers get better results with their marketing investments by providing advanced technology across digital channels. Through the Perion One platform, we are making digital advertising more effective by building solutions that continuously adapt to connect the dots between data, creative and channels. For more information, visit Perion's website at www.perion.com
Article content
About Greenbids
Article content
Greenbids is an AI-powered media buying optimization platform, purpose-built to bring clarity, performance, and intelligence back to digital advertising. It integrates seamlessly with leading ad platforms, including Programmatic, Meta, and YouTube to improve media quality, boost efficiency, and maximize return on investment. Greenbids helps top advertisers simplify execution, eliminate supply chain inefficiencies, and future-proof their marketing strategies for smarter, faster, and more sustainable results.
Article content
Forward Looking Statements
Article content
This press release contains historical information and forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the safe- harbor provisions of the Private Securities Litigation Reform Act of 1995 with respect to the business, financial condition and results of operations of Perion. The words 'will,' 'believe,' 'expect,' 'intend,' 'plan,' 'should,' 'estimate' and similar expressions are intended to identify forward-looking statements. Such statements reflect the current views, assumptions and expectations of Perion with respect to future events and are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements. Many factors could cause the actual results, performance or achievements of Perion to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, or financial information, including, but not limited to, political, economic and other developments (including the current war between Israel and Hamas and other armed groups in the region), the failure to realize the anticipated benefits of companies and businesses we acquired and may acquire in the future, risks entailed in integrating the companies and businesses we acquire, including employee retention and customer acceptance, the risk that such transactions will divert management and other resources from the ongoing operations of the business or otherwise disrupt the conduct of those businesses, and general risks associated with the business of Perion including, the transformation in our strategy, intended to unify our business units under the Perion brand (Perion One), intense and frequent changes in the markets in which the businesses operate and in general economic and business conditions (including the fluctuation of our share price), loss of key customers or of other partners that are material to our business, the outcome of any pending or future proceedings against Perion, data breaches, cyber-attacks and other similar incidents, unpredictable sales cycles, competitive pressures, market acceptance of new products and of the Perion One strategy, changes in applicable laws and regulations as well as industry self-regulation, negative or unexpected tax consequences, inability to meet efficiency and cost reduction objectives, changes in business strategy and various other factors, whether referenced or not referenced in this press release. We urge you to consider those factors, together with the other risks and uncertainties described in our most recent Annual Report on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission (SEC) on March 25, 2025, and our other reports filed with the SEC, in evaluating our forward-looking statements and other risks and uncertainties that may affect Perion and its results of operations. Perion does not assume any obligation to update these forward-looking statements.
Article content
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
19 minutes ago
- Globe and Mail
Could Investing $10,000 in Markel Make You a Millionaire?
Turning a $10,000 investment into $1 million or more would mean a 100X result. But it isn't as far-fetched as it might seem, and you don't necessarily need to invest in volatile high-tech companies to make it happen. One of my favorite candidates to be a millionaire-making stock in my own portfolio is insurance company Markel (NYSE: MKL), which does things much differently than its insurance industry peers. In fact, Markel's business model often draws comparisons to an early stage Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), and to say that Berkshire has been a millionaire maker would be a major understatement. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » With that in mind, here's a brief overview of Markel's business model, why the stock could be a good value today, and how it could turn $10,000 into a million-dollar investment simply by continuing to execute on its time-tested growth strategy. Markel in a nutshell If you aren't familiar with Markel, here's a quick overview of its business. There are three main components. At its core, Markel is an insurance company. It mainly operates in specialty insurance (the excess and surplus, or E&S lines, in insurance terms) and reinsurance. These are types of insurance that can be rather difficult, but that have enormous profit potential. In addition, Markel invests some of its float in the stock market, similar to Berkshire Hathaway. As of the latest information, Markel owned about $11.3 billion worth of stocks (and the largest holding happens to be Berkshire). The company's equity investments have delivered 12.8% annualized returns over the past five years. Finally, Markel Ventures is the company's division that acquires entire businesses. Unlike Berkshire, which needs to buy massive companies to move the needle, Markel has the luxury that it can invest a meaningful amount of money in early stage businesses with lots of growth potential. Just to name a few examples, Markel Ventures owns a luxury handbag maker, a houseplant company, a homebuilder, and several others. Last year, Markel Ventures generated $5.1 billion in revenue. This isn't exactly Berkshire's business model, but it's a pretty similar one. And it follows one of Warren Buffett's top rules for conglomerate building: Be willing to own minority shares of businesses (common stocks) while pursuing opportunistic ways to own entire companies as well. Over the 60-year period that Warren Buffett has run Berkshire Hathaway, this has resulted in a total return of more than 5,500,000%. To say that this is a time-tested model would be an understatement. A 'baby Berkshire' at a discount Markel recently announced a strategic review of its business due to lackluster profitability in its insurance business and generally subpar stock performance. Just to name a few things that have already been done, Markel decided to pull the plug on several unprofitable insurance lines and has already decided that improving the technology capabilities of its insurance business needs to be a priority. According to management, Markel's intrinsic value has grown at an 18% annualized rate over the past five years. But its stock price has only grown at a 9% rate. Management estimates a $2,610 per-share intrinsic value for the business, and the stock trades for about $1,935 as I'm writing this. That's a big valuation gap. Management also announced a $2 billion stock buyback program along with the review and said that this will be a near-term focus of capital deployment. So, the company believes its stock price doesn't reflect the business' value and is putting its money where its mouth is. Could Markel make you a millionaire? The short answer is yes. But it's unlikely to happen quickly. Markel is designed to be a long-term compounder that can produce returns that are superior to the overall stock market. Over long periods, the S&P 500 has produced total returns of about 10% annualized, and in the modern era (since Warren Buffett has been running the company), Berkshire Hathaway has produced 19.9% annualized returns. So, assuming that Markel successfully beats the S&P over the long term, here's how long it could take to turn a $10,000 investment into $1 million: Long-Term Annualized Total Return Years to Turn $10k Into $1 Million 12% 42 14% 36 16% 32 18% 29 20% 26 Data source: Author's own calculations. Years are rounded to the nearest whole number. Now, I don't necessarily think Markel, or any other company, will produce Berkshire-like returns over a 60-year period. But I do believe that with Markel's strategy, it's entirely possible to significantly outpace the market. In short, the most likely scenario (which would still be very impressive) would be one of the first few rows in the chart. For context, since it went public in 1986, Markel has delivered 15% annualized returns, so there is real-world evidence that the company can beat the market. Of course, this assumes that you invest $10,000 once. The best way to approach a stock like Markel or Berkshire Hathaway (or most other compounding-focused stocks for that matter) is to invest incrementally over time. But the point is that even with a single investment, a stock with steady market-beating returns can have massive wealth-building potential over time. Should you invest $1,000 in Markel Group right now? Before you buy stock in Markel Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Markel Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor 's total average return is996% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
Globe and Mail
2 hours ago
- Globe and Mail
Prediction: Nvidia Stock Is Going to Hit $200 in 2025
Nvidia (NASDAQ: NVDA) stock has soared by 870% since the start of 2023, catapulting its market capitalization to a whopping $3.5 trillion. Demand continues to exceed supply for the company's graphics processing units (GPUs) for the data center, which are the most powerful chips in the world for developing artificial intelligence (AI) models. Nvidia CEO Jensen Huang says new AI reasoning models, which spend more time thinking to produce accurate responses, require up to 1,000 times more computing capacity than traditional large language models (LLMs). As a result, he thinks data center spending will reach $1 trillion per year by 2028 as companies race to meet that demand. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Nvidia is gearing up for the strongest year in its history thanks to its latest GPU architectures, which offer more performance than anything else on the market right now. Nvidia stock is trading at around $142 as of this writing (June 10), but here's why I think it's on the way to $200 before year-end. Nvidia is racing to launch new chips to meet demand Nvidia's Hopper architecture was at the foundation of its H100 GPU, which was the top-selling AI data center chip in 2023 and for most of 2024. It was superseded late last year by the Blackwell architecture, with GPUs like the GB200 producing up to 40 times more performance than the H100 in specific configurations. This is ideal for inference workloads, which is the process by which AI models analyze data to produce responses for the end user. Inference demand is soaring because of the reasoning models I mentioned, which include OpenAI's GPT-o3 and o4, Anthropic's Claude 4, Meta Platforms ' Llama 4, DeepSeek's R2, and more. Previous LLMs were great at generating one-shot responses that created a fast and convenient user experience, but they sometimes produced inaccurate information. Reasoning models refine their responses in the background before delivering them to the user, which takes longer and consumes significantly more tokens (words, punctuation, and symbols) -- between 100 and 1,000 times more, according to Jensen Huang. Therefore, it's possible Blackwell's 40-fold performance leap over Hopper still isn't enough for some reasoning models, which could lead to a sluggish user experience. Nvidia recently launched Blackwell Ultra, which offers a slightly better 50-fold improvement over Hopper, but developers will have to wait until next year for the next major jump in performance. That's because Nvidia will start shipping a lineup of GPUs based on its new Rubin architecture in 2026, which could be 3.3 times faster than Blackwell Ultra -- or around 165 times faster than Hopper. This constant chase for performance is why Huang thinks annual data center spending is heading toward $1 trillion in 2028, and the company with the most powerful chips is likely to capture the most market share. Wall Street's consensus estimate (provided by Yahoo! Finance) suggests Nvidia could generate a record $200 billion in revenue during its fiscal year 2026 (which ends on Jan. 30, 2027). Based on the company's recent financial results, the data center segment will account for around 89% of that revenue, which is why AI and GPU sales are the main focus for investors right now. Nvidia stock has a pathway to $200 this year Nvidia generated $3.19 in earnings per share (EPS) over the last four quarters, which places its stock at a price-to-earnings (P/E) ratio of 46. That is comfortably below its 10-year average of 59.9, suggesting the stock might be undervalued right now. Plus, Wall Street expects Nvidia to deliver up to $4.27 in EPS during fiscal 2026, placing its stock at a forward P/E ratio of 33.4: NVDA PE Ratio data by YCharts That means Nvidia stock would have to climb by 38% over the next nine months just to maintain its current P/E ratio of 46, and it would have to soar by 79% to trade in line with its 10-year average P/E ratio of 59.9. That would place Nvidia stock somewhere between $196 and $254 in the early stages of 2026. However, the stock market is a forward-looking machine, so investors usually start pricing in future earnings ahead of time. That's why I predict Nvidia stock will surpass $200 before 2025 is over. If Jensen Huang provides a bullish update on next year's Rubin GPUs, Wall Street analysts might even raise their EPS estimates, which would be another upside catalyst for the stock. But no matter what happens in the remainder of this year, investors should stay focused on the long term, because if data center operators spend $1 trillion annually on AI infrastructure by 2028, as Huang expects, $200 might actually be a bargain for Nvidia stock when we look back on this moment in the future. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor 's total average return is996% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
Globe and Mail
2 hours ago
- Globe and Mail
Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge
UnitedHealth Group (NYSE: UNH) might want to change its stock ticker from "UNH" to "UGH." The latter better captures the feelings of the healthcare giant's shareholders in recent months. A string of problems has caused UnitedHealth Group's share price to plunge roughly 50% from the peak set in the fourth quarter of 2024. Some analysts have downgraded the stock, with HSBC recommending that investors reduce their holdings and slashing its price target. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » I have a different opinion, though. I think it's time to buy UnitedHealth Group stock. Here are three reasons why. 1. Most of the company's problems should be temporary I don't think investors should ignore UnitedHealth Group's issues. However, the challenges should be viewed with a long-term perspective. I suspect most of the problems the company faces should be temporary. UnitedHealth Group has already largely moved past the cyberattack that occurred in February 2024. Although it cost the healthcare company over $2 billion, that issue has already proven to be a short-lived one. Higher Medicare Advantage costs are the main culprit behind UnitedHealth Group's suspension of its 2025 full-year guidance. But the company says that it expects to return to growth in 2026. I believe this prediction because it makes sense. Insurers sometimes incur higher-than-anticipated costs and feel the pain for a while. However, once they adjust premiums, the problem goes away. UnitedHealth Group announced the sudden departure of former CEO Andrew Witty at the same time it withdrew its 2025 outlook. Any worries investors might have had surrounding this move probably dissipated quickly after they learned Stephen Hemsley was returning to run the company. Hemsley served as CEO from 2006 through 2017, a period when UnitedHealth Group stock more than tripled. 2. The two biggest threats to UnitedHealth Group are iffy I also view the two biggest threats to UnitedHealth Group as iffy. What are those threats? An alleged U.S. Department of Justice criminal investigation of the company and President Trump's stated goal to eliminate pharmacy benefits managers (PBMs). Noted that I used the word "alleged" to describe the U.S. Department of Justice probe. The Wall Street Journal reported on May 14, 2025, that "people familiar with the matter" revealed that the DOJ had launched a criminal investigation of UnitedHealth Group for possible Medicare fraud. However, the company quickly responded that it hadn't been notified of any DOJ investigation. That status hasn't changed. President Trump did announce that he wants to "cut out the middleman," a clear reference to PBMs. That's easier said than done, though, to put it mildly. Removing PBMs from the U.S. healthcare system would require a detailed, comprehensive plan that so far has not been provided. That plan would also have to pass in both the Senate and the House of Representatives. You can bet that the PBM industry, including UnitedHealth Group, would lobby fiercely against any such legislation. I think this threat, while serious, has a relatively low probability of actually materializing. 3. The price is right Finally, I think all these issues are fully baked into UnitedHealth Group's share price. The stock currently trades at a forward price-to-earnings ratio of around 13.3. That's well below the S&P 500 healthcare sector forward earnings multiple of 16.6. It's also the lowest valuation for UnitedHealth Group in more than a decade. Could the stock fall further? Maybe, but I believe that UnitedHealth Group's share price has bottomed out. You might have noticed that UnitedHealth Group's share price has traded in a relatively narrow range since the steep decline in April and May. This trading pattern seems to confirm my view. Any good news for UnitedHealth Group could provide a nice catalyst. I predict that the company will have some positive developments in the not-too-distant future, potentially including new full-year guidance that calms investors. If I'm right, buying UnitedHealth Group stock now could pay off handsomely. Should you invest $1,000 in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor 's total average return is996% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
